Key result
Non-Western migrants had lower relative risks for initiating ADP-inhibitors (RR 0.93; 95% CI 0.90-0.96) and higher hazard ratios for discontinuing statins (HR 1.64; 95% CI 1.45-1.86) after ACS.
Why the study?
Does non-Western migrant status affect the initiation and discontinuation of preventive therapies after ACS compared to the Danish-born population?
Cohort (n=33,199)
Yes
Does non-Western migrant status affect the initiation and discontinuation of preventive therapies after ACS compared to the Danish-born population?
Non-Western migrants in Denmark have lower initiation and higher discontinuation rates of secondary prevention therapies after ACS compared to the native-born population, independent of comorbidity and sociodemographic factors.
Disparities may affect post-ACS outcomes in non-Western migrants; hypothesis-generating and requires prospective confirmation before guiding interventions.
Aims: The aim of this article is to assess initiation and discontinuation of preventive medication and use of non-pharmacological prevention interventions after acute coronary syndrome (ACS) among migrants to Denmark compared to the local-born Danish population, taking differences in comorbidity and sociodemographic factors into account. Methods and results: In this large cohort study, we selected the population (n = 33 199) from nationwide registers and followed each individual among migrants and Danish-born 180 days after ACS. We identified the initiation and discontinuation of medications and the initiation and number of contacts for non-pharmacological interventions in the Register of Medicinal Products Statistics and the National Patient Register, and adjusted for comorbidity and sociodemographic factors. Non-Western migrants had lower relative risks for initiating adenosine diphosphate receptor (ADP)- and angiotensin-converting enzyme (ACE)-inhibitors (0.93, CI: 0.90; 0.96, and 0.91, CI: 0.87; 0.96) and patient education (0.95, CI: 0.92; 0.98). Further, non-Western migrants had higher hazard ratios for discontinuing medications (statins: 1.64, CI: 1.45; 1.86, ADP-inhibitors: 1.72, CI: 1.50; 1.97, β-blockers: 1.52, CI: 1.40; 1.64, and ACE-inhibitors: 1.72, CI: 1.46; 2.02), and fewer contacts for physical exercise and patient education (P < 0.001 and P = 0.011). Conclusion: We identified differences between non-Western migrants and Danish-born in initiation and discontinuation of preventive medications and use of non-pharmacological interventions after ACS. These differences could not be explained by differences in comorbidity or sociodemographic factors.
No takes yet. Share an insight, caveat, or question.
Frederiksen et al. (2018) conducted a cohort in Acute coronary syndrome (n=33,199). Non-Western migrant status vs. Local-born Danish population was evaluated on Initiation of ADP-inhibitors (RR 0.93, 95% CI 0.90-0.96). Non-Western migrants had lower relative risks for initiating ADP-inhibitors (RR 0.93; 95% CI 0.90-0.96) and higher hazard ratios for discontinuing statins (HR 1.64; 95% CI 1.45-1.86) after ACS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: